The New Jersey Supreme Court on Thursday offered a balm to New Jersey drug companies, ruling that consumers can’t necessarily avail themselves of New Jersey’s plaintiff-friendly product liability law in circumstances where their own state’s law drastically limits recovery.
The court ruled, 5-2, in Rowe v. Hoffmann-La Roche Inc., A-16-06, that Michigan law should apply to a suit by a Michigan man who attempted suicide after taking the acne-treatment drug Accutane, made in New Jersey by Hoffmann-La Roche Inc.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
